Donal N Gorman (Donal Gorman)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Pulmonary Artery

Top Venues

Nature medicine

British journal of clinical pharmacology

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Chay Ngee Lim, Constantino Kantaridis, Isabelle Huyghe, Donal N Gorman, Stephen Berasi, Gabriele E Sonnenberg
A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants. Pharmacology research & perspectives 9 (4) (2022)
Aditi R Saxena, Donal N Gorman, Ryan M Esquejo, Arthur Bergman, Kristin Chidsey, Clare Buckeridge, David A Griffith, Albert M Kim
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial. Nature medicine 27 (6) (2021)
Peter Loudon, Pieter Siebenga, Donal N Gorman, Katrina Gore, Pinky Dua, Guido van Amerongen, Justin L Hay, Geert Jan Groeneveld, Richard P Butt
Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models. British journal of clinical pharmacology 84 (2) (2017)